Palliative radiotherapy in esophageal cancer with or without chemotherapy.
Phase 2
- Conditions
- Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified
- Registration Number
- CTRI/2024/07/070918
- Lead Sponsor
- Post Graduate Institute of medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Biopsy proven Squamous cell carcinoma esophagus.
Willing to participate
Not suitable for definitive chemoradiation therapy.
Advanced stage disease
KPS more than 70.
Exclusion Criteria
Pregnant females.
Early stage disease.
Not willing to participate
Patient not fit for chemotherapy due to comorbidities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess for response comparing both the groups.Timepoint: At 6 weeks post Radiotherapy then after 3 monthly interval for 1 year.
- Secondary Outcome Measures
Name Time Method To assess for survival comparing both the groups.Timepoint: at 6 months and then at every 3 month interval for 1 year.